MicroConstants Blog The State Of The Biosimilars Market

3 key challenges facing the biosimilars space in 2023 In 2010, the biopharma industry saw an abrupt patent cliff: a significant number of top-selling drugs lost exclusivity. Once these originator products came off patent, the race was on between competing developers to gain approval first and reap the market share advantage. In the next eight [...]Share ThisThe post The State Of The Biosimilars Market appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.